Punch & Associates Investment Management, Inc. Fibrogen Inc Transaction History

Punch & Associates Investment Management, Inc.

  • $1.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$31.0 - $55.72 $279,000 - $501,480
-9,000 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$45.35 - $61.65 $502,523 - $683,143
-11,081 Reduced 55.18%
9,000 $416,000
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $670,705 - $1.08 Million
20,081
20,081 $1.08 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email